Microsoft's Surface Pro Tablet Makes its Debut and Sells Out Fast; the Company was One of the Few to Defy the Dow's Loss... (es on the Internet social networking sit...)

HOME >> MEDICINE >> TECHNOLOGY

Microsoft's Surface Pro Tablet Makes its Debut and Sells Out Fast; the Company was One of the Few to Defy the Dow's Loss Yesterday

Date:2/12/2013

es on the Internet, social networking sites, and mobile platforms.

Novo Nordisk A/S (NYSE: NVO) - NVO shares dropped yesterday after the U.S. Food and Drug Administration asked for further testing on the treatments of the Company's new insulin products. Novo said they won't be able to complete the request this year. Volume on Monday was significantly higher than average at 2,267,599 shares traded. The stock closed at 165.40, down 13.98%. Analysts polled by FactSet are calling for Novo Nordisk to earn $8.38 a share for the year. Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally.

Zion Oil & Gas, Inc. (Nasdaq: ZN) - Zion Oil & Gas was one of the biggest gainers on the Nasdaq yesterday. The stock saw unusually high trading volume on Monday, and closed up 27.21% at $1.59. Volume traded was more than ten times higher than usual at 1,412,630 shares. ZN was trading as low as $0.81 at the end of January. On Monday the stock saw an intra-day high of $1.75, representing gains of over 100%. Zion Oil & Gas, Inc. operates as a development stage oil and gas exploration company in Israel.

ModusLink Global Solutions, Inc. (Nasdaq: MLNK) - MLNK soared as much as 20% on Monday when it hit an intra-day high of $3.40. Yesterday morning news came out announcing that New York-based Steel Partners Holdings L.P. will invest $30 million in return for several changes to ModusLink's board of directors. Under the terms of the agreement, Steel Holdings would purchase 7.5 million newly issued shares of common stock at a price of $4.00 per share, representing a
'/>"/>

SOURCE www.thestockfreak.com
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Arthrosurface Hits a $100 Million Milestone
2. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
3. Apollo Hospitals Perform Revolutionary Minimally Invasive Knee Replacement (Resurfacement) Surgery
4. Mylan Launches Generic Version of Zyprexa® Tablets
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. Mylan Launches Generic Version of Plavix® Tablets
7. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
8. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
9. Mylan Launches Generic Version of Viramune® Tablets
10. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
11. FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options. ...

(Date:5/22/2013)... 22, 2013 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... of the company at the following conferences. , ... date: Wednesday May 29, 2013 , Presentation time: 12:00 ... Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of these ...

(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...

Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4 Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3

[0] Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures [0] Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences [0] Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

... NEW YORK, Nov. 8, 2010 Reportlinker.com ... is available in its catalogue: ... Technology platforms, key players, and early pipeline ... Therapeutic vaccines promise a ...

... Nov. 8, 2010 Reportlinker.com announces that ... in its catalogue: Opportunities ... growth in key regions and therapeutic areas ... The flurry of recent industry acquisitions ...

Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas

(Date:5/22/2013)... Margate City, NJ (PRWEB) May 22, 2013 ... from solved. In some states, up to twenty-seven percent ... half of all bankruptcies of private citizens in the U.S. ... medical care also affects prescription drugs, meaning that many patients ... doctor, or even get them filled at all. That's ...

(Date:5/22/2013)... Beginning Aug. 22, teens are invited ... Spirit of Innovation Challenge . The annual program ... and open to students ages 13 - 18 from ... Challenge celebrates the life and entrepreneurial spirit of astronaut ... The program challenges teens to work in teams of ...

(Date:5/22/2013)... May 22, 2013 The 2013 release of ... is the largest change to hit the field of mental ... is will help prepare for the release with a Webinar ... been trained knowing no other diagnostic scheme besides the now ... manual will be released worldwide. In honor of this event, ...

(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...

(Date:5/22/2013)... May 22 2013 - Research presented today shows ... in rats similar to those produced by drugs ... presented by addiction expert Francesco Leri, Associate Professor ... University of Guelph, suggest food addiction could explain, ... These results were presented at the 2013 ...

Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2 Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2 Health News:What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 2 Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2 Health News:Addiction to unhealthy foods could help explain the global obesity epidemic 2

[0] Lyrica Discount Cards Now Available From MedicationDiscountCard.com [0] Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date [0] What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 [0] Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative [0] Addiction to unhealthy foods could help explain the global obesity epidemic

... the standard treatment regimen for hepatitis C significantly increases the ... to a research report published Monday in the online edition ... team, led by Paul Kwo, M.D., of Indiana University School ... treatment,s effectiveness when given for 48 weeks in one treatment ...

... by researchers at the Bradley Hasbro Children,s Research Center ... some of the well-documented ethnic disparities in pediatric asthma. ... children in the study tended to think they were ... tests actually revealed normal lung function. According to ...

... Adding a direct acting anti-viral drug to the standard ... in the most difficult to treat patients, according to a ... journal The Lancet . The research team, led ... reported that adding the drug nearly doubled the treatment,s effectiveness ...

... The University of Colorado College of Nursing has been ... Health and Human Services, Health Resources and Services Administration ... to provide leadership for high quality healthcare in rural ... a competitively awarded grant to i-LEAD, Innovation in Leadership ...

... Reporter , FRIDAY, Aug. 6 (HealthDay News) -- "Locally grown" ... It,s a concept that has made many Americans scan their ... been raised nearby. But are locally grown foods necessarily ... grown locally will be much healthier; others, not so much. ...

... 2010 SIRIUS XM Radio (NASDAQ: SIRI) today announced ... Doctor Radio Reports: Understanding Autism - Looking for Answers, ... Perri Peltz on which a panel of world-class doctors, ... the latest research and treatment options for autism and ...

Cached Medicine News:Health News:New antiviral drug shows promise for dramatic improvement in hepatitis C treatment 2 Health News:New antiviral drug shows promise for dramatic improvement in hepatitis C treatment 3 Health News:Latino children with asthma less accurate in determining their lung function 2 Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 2 Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 3 Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 2 Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 3 Health News:'Locally Grown' May Mean Healthier, But Not Always 2 Health News:'Locally Grown' May Mean Healthier, But Not Always 3 Health News:Sirius XM to broadcast 'Doctor Radio Reports: Understanding Autism -- Looking for Answers' 2

New antiviral drug shows promise for dramatic improvement in hepatitis C treatment Latino children with asthma less accurate in determining their lung function New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment College of Nursing awarded grant for nursing leadership in rural and underserved areas 'Locally Grown' May Mean Healthier, But Not Always Sirius XM to broadcast 'Doctor Radio Reports: Understanding Autism -- Looking for Answers'

... The Summit SI Spinal Fixation ... for rigid posterior fixation of ... spine. The simplicity and versatility ... optimize the construct based on ...

OctaFix is designed specifically to provide stability and fixation where it is most needed....

...

Medicine Products:

Summit SI Spinal Fixation System Octafix Adson Cranial Rongeur Bateman Rongeur